Skip to main content

Advertisement

Log in

Do anti-CGRP drugs have a role in migraine aura therapy?

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ashina M (2020) Migraine. N Engl J Med 383:1866–1876

    Article  CAS  Google Scholar 

  2. Edvinsson L (2019) Role of CGRP in migraine. Handb Exp Pharmacol 255:121–130

    Article  CAS  Google Scholar 

  3. Urits I, Jones MR, Gress K et al (2019) CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep 23:29

    Article  Google Scholar 

  4. Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730–1732

    Article  CAS  Google Scholar 

  5. Hansen JM, Charles A (2019) Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs. J Headache Pain 20:96

    Article  Google Scholar 

  6. Durham PL, Garrett FG (2009) Neurological mechanisms of migraine: potential of the gap-junction modulator tonabersat in prevention of migraine. Cephalalgia 29(Suppl 2):1–6

    Article  Google Scholar 

  7. Close LN, Eftekhari S, Wang M, Charles AC, Russo AF (2019) Cortical spreading depression as a site of origin for migraine: role of CGRP. Cephalalgia 39:428–434

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Cecilia Baroncini who edited the English text.

Funding

The authors declare that they have nothing to report.

Author information

Authors and Affiliations

Authors

Contributions

EM and UP analysed the data and drafted the manuscript; VF, GG, GP and SC acquired and analysed data, and critically revised the manuscript. SC conceived and designed the study.

Corresponding author

Correspondence to Sabina Cevoli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies involving human participants performed by any of the authors.

Consent to participate

Written informed consent was collected from the patient for the inclusion of deidentified clinical data in a scientific publication, in accordance with the Declaration of Helsinki.

Consent for publication

All Authors agreed with this final version.

Availability of data and materials

The authors take full responsibility for the data, the analysis, and interpretation of the research, and they have full access to all of the data.

Code availability

Not applicable.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 78 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matteo, E., Pensato, U., Favoni, V. et al. Do anti-CGRP drugs have a role in migraine aura therapy?. J Neurol 268, 2273–2274 (2021). https://doi.org/10.1007/s00415-021-10546-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10546-1

Navigation